SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001564590-21-028426
Filing Date
2021-05-17
Accepted
2021-05-17 16:33:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 cere-424b3.htm 424B3 2227504
2 GRAPHIC gfs2ihgbcuis000001.jpg GRAPHIC 20723
3 GRAPHIC gfs2ihgbcuis000002.jpg GRAPHIC 102858
  Complete submission text file 0001564590-21-028426.txt   2399071
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-250964 | Film No.: 21931419
SIC: 2834 Pharmaceutical Preparations